Coty Inc. is a global beauty company that specializes in the development, manufacturing, and marketing of a wide range of beauty products, including perfumes, cosmetics, and skincare solutions. With a diverse portfolio that includes both established and emerging brands, Coty aims to enhance the beauty experience for consumers through innovative and high-quality offerings. The company focuses on creating iconic fragrances, cutting-edge makeup products, and luxurious skincare treatments, catering to a variety of customer preferences and market segments. Through its commitment to sustainability and social responsibility, Coty continues to evolve its product lines and business practices to meet the changing needs of consumers around the world. Read More
Date: February 6, 2026 Introduction The high-stakes world of prestige beauty was sent into a tailspin yesterday as The Estée Lauder Companies Inc. (NYSE: EL) witnessed a dramatic 19.2% collapse in its share price. The sell-off, which represents one of the steepest single-day declines in the company’s nearly 80-year history, came on the heels of [...]
Beauty products company Coty (NYSE:COTY) announced better-than-expected revenue in Q4 CY2025, but sales were flat year on year at $1.68 billion. Its non-GAAP profit of $0.14 per share was 24.2% below analysts’ consensus estimates.
Today, Coty Inc. (NYSE: COTY) (Paris: COTY) announces a strategic collaboration with OpenAI to expand the use of advanced artificial intelligence tools across selected areas of its global organization. With ChatGPT Enterprise, Coty employees will gain access to OpenAI’s most capable models with enterprise-grade security and privacy, supporting daily work and cross functional collaboration. This first phase gives targeted teams access to secure, enterprise grade AI tools, with the flexibility to scale based on Coty’s evolving needs.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Soleno Therapeutics, Inc. (NASDAQ:SLNO), AVITA Medical, Inc. (NASDAQ:RCEL), and Coty, Inc. (NYSE:COTY). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
Coty has gotten torched over the last six months - since July 2025, its stock price has dropped 35.8% to $3.19 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
As of late 2025, The Estée Lauder Companies (NYSE: EL) stands at a pivotal crossroads in its nearly 80-year history. Once the undisputed champion of the prestige beauty world, the company spent much of the early 2020s navigating a "perfect storm" of inventory gluts, an over-reliance on the Chinese travel retail market, and a leadership [...]
The past year hasn't been kind to the stocks featured in this article.
Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling knives.
Shares of beauty products company Coty (NYSE:COTY)
fell 5.3% in the morning session after the company announced CEO Sue Nabi would step down, prompting a downgrade from Evercore ISI.
The company has had a whirlwind year, selling a stake in Kim K’s Skims, initiating a strategic review of its consumer beauty business, and now having a new interim CEO.
Coty has sold its remaining 25.8% stake in Wella to KKR-managed capital accounts and investment affiliates for an upfront cash payment of $775 million.
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10.
However, a disciplined approach is necessary because many of these businesses are speculative and lack the underlying fundamentals to support their prices.
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE:AGL), Soleno Therapeutics, Inc. (NASDAQ:SLNO), AVITA Medical, Inc. (NASDAQ:RCEL), and Coty, Inc. (NYSE:COTY). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
